• Enuresis alarm therapy is first-line treatment for bedwetting.
INTRODUCTION
Enuresis affects up to 20% of children 1 and impacts on sleep, self-esteem and quality of life, which can be reversed with successful treatment [2] [3] [4] . In enuresis, the normal arousal response to bladder distension is defective during sleep, with polysomnographic changes from deep to light sleep occurring without conscious awakening in many 5, 6 . Alarm therapy, the first line treatment for enuresis 7 , conditions the child to wake to an auditory stimuli with wetting and either void in the toilet or inhibit voiding by contracting their urethral sphincter 8 , eventually learning to wake in response to bladder distension during sleep. Although this simple therapy is often effective, failure is common (25-35%) 7 , and thought to be due to failure to wake to the alarm or poor adherence to treatment.
Although high sleep arousal thresholds is thought to be the reason why children fail to wake to the alarm, poor motivation to wake may also be a contributing factor. Motivation has been shown to enhance arousal to auditory stimuli during sleep in adults 9 . We hypothesized that by producing a higher level of arousal during alarm training, the arousal response to bladder distension during sleep would improve resulting in better treatment outcomes. We designed Before enrolment, potential participants completed a 14-day bladder diary to determine eligibility and baseline measurements, and a questionnaire to identify demographic details, severity of wetting, type of enuresis (monosymptomatic or non-monosymptomatic) and previous treatments received.
Study design: Participants were randomly assigned to either the code-word alarm or a commercially available wireless enuresis alarm. Treatment ceased after 16 weeks of alarm training or when the child achieved 14 consecutive dry nights (whichever came first), as recommended by the National Institute for Health and Care Excellence (NICE) Guidelines 10 .
The randomisation sequence was computer generated and stratified according to gender and age by the method of minimization, and performed by an independent randomization service.
Allocation occurred via a telephone call to the service, with investigators, clinicians and data analysts unaware of group assignment. Families were aware of their assigned alarm but were unaware which was the 'novel' arm because the control alarm was not commercially available in Australia at the time of the study and therefore both alarms looked unfamiliar.
Interventions:
The code-word alarm delivered a pre-recorded personalised code word when the child wet at night. Children were encouraged to remember the code word the next morning. We instructed the parents to reward recall, but did not specify what the reward should be. We hypothesised that a higher level of arousal is required for remembering and recalling a code word than from waking to the sound of the alarm, the standard method for arousal.
The code-word alarm comprised of a wireless wetness sensor (secured in a pad worn inside the child's underpants) and an alarm box (containing a digital voice recorder for parents to record personalised code words for their child) located beside the child's bed. When wetting occurred, moisture was detected by the sensor and the alarm sounded. When the child woke and deactivated the alarm, the pre-recorded code word was announced and the child was encouraged by their parents to wake and void in the toilet. This code word changed daily.
The control alarm was a wireless alarm that was commercially available in the United
Kingdom at the time of the study (http://www.malemmedical.com/wireless-alarm-recordwetness-sensor-and-toilet-trainer). The attachment of the sensor and location of the alarm box was similar to the experimental group. When wetting occurred, the alarm sounded with an identical noise to the code-word alarm, and the child was encouraged by their parents to wake and void in the toilet. However, there was no pre-recorded code word with the control alarm.
To ensure the treatments received by both groups were as similar as possible, instructional
DVDs with identical wording (apart from the instructions for setting the code word for the experimental alarm) were provided to families.
Outcomes: Standardised outcomes were reported using the 2006 International Children's Continence Society (ICCS) definitions 11 . We compared frequency of wetting over 14 days at baseline with the end of treatment. In the original 2006 ICCS definition, a "full response"
was defined as 14 consecutive dry nights (or completely dry), "response" as 90% to 99% reduction in enuresis compared with baseline, "partial response" as 50 to 89% reduction and "nonresponse" as 0 to 49% reduction. We added a "worse" category for those whose wetting increased. Relapse was defined as more than one wet night per month after achieving full response and continued success was no relapse within 6 months of ceasing treatment.
The ICCS definitions changed in 2014 12 and we have also reported outcomes using these updated definitions as a sensitivity analysis. In the 2014 definitions, the term "full response" was changed to "complete response", "partial response" was redefined as 50 to 99%
reduction and "non-response" was less than 50% reduction in wetting compared with baseline.
The primary outcome was the proportion of children who achieved full response (14 consecutive dry nights) in the experimental and control groups by 16 weeks. Secondary outcomes were change in frequency of wetting over 14 nights, achieving more than 50% reduction in wetting compared with baseline, duration of alarm training, percentage of wet nights that the child woke to the alarm, adherence to treatment, discontinuation of alarm therapy before achieving a full response, adverse events and satisfaction with treatment by parents and children. We chose waking to the alarm as an outcome of interest as we wanted to assess whether improved waking will result in improved treatment outcomes. Waking was determined by diary records of the child being able to recall the code word the next morning in the experimental group and the child speaking to the parents when the alarm sounded for controls. Adherence to alarm training was measured as the percentage of nights on treatment that the child wore the alarm. For those who chose to discontinue alarm training, the date they discontinued treatment was used as their end of treatment date. In those who achieved a full response, we also compared the time to achieve a full response and relapse within 6 months of ceasing alarm training. The relapse rate was used to assess the sustainability of the alarm training after cessation of treatment.
Follow up procedures:
The study coordinator contacted participants bi-weekly during alarm training and bi-monthly after cessation of treatment for a total of 12 months from enrolment.
Parents were requested to complete diaries recording treatment response and adherence to treatment during alarm training, and wet nights after cessation of treatment. Routine clinical care was provided after cessation of alarm training, including the use of medication or further alarm training as appropriate.
Statistical methods:
We aimed to recruit 320 children (160 in each study group), assuming a full response rate of 65% in the control group (as reported in previous studies)the code-word alarm group (based upon single arm pilot data). This number would provide an 80% power to detect a difference of at least 15%, with a two-sided type I error of 5% and assuming a non-adherence rate of 10%.
We used an intention-to-treat approach and included patients who discontinued alarm training before achieving a full response in the denominator. Descriptive results were presented as frequencies and percentages for categorical variables and as medians and interquartile range (IQR) for continuous variables. In our primary analysis, we compared the proportion of children who attained a full response by 16 weeks in the experimental and control groups.
The response of those who discontinued alarm therapy before achieving a full response and those who continued to wet at 16 weeks were derived from their treatment diaries as coded at the time of alarm discontinuation. The chi-squared statistic was used to test for a difference between proportions and the Mann-Whitney test applied to continuous variables, due to the skewness of their distribution.
A follow-up relapse at 6 months was defined for a child if one or more bi-monthly contacts reported a relapse during that time period. If one or more bi-monthly contacts were missing, the relapse status at 6 months was based on the available contact information. We repeated the analysis on the subset of children who had complete information for all bi-monthly contacts as a sensitivity analysis and the results were similar. Although relapse at 12 months was an outcome initially planned in the protocol, the amount of missing data did not allow us to analyse it.
As most previously published data on alarm therapy for enuresis was conducted in children with monosymptomatic enuresis (bedwetting only) 7 , we conducted a post-hoc subgroup analysis of these patients. This population is known to be more responsive to alarm therapy and the subgroup analysis enabled our study to be compared with other studies of alarm 
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83457. All alarms used in the trial were purchased or built by the research team.
RESULTS
The study was conducted at the Children's Hospital at Westmead, Sydney, Australia. Three hundred and fifty three children were enrolled in the study between May 2009 and December 2010, with 176 allocated to the code-word alarm and 177 to the control alarm ( Figure 1 ).
There were two (1.1%) children lost to follow up in each arm. Although we were able to obtain information about their response at 16 weeks, we were unable to obtain diary data on other outcomes (Figure 1 ).
Baseline characteristics were well matched, with the median age being 8.4 and 8.1 years, 62
and 60% being male, 88 and 90% with primary enuresis and 56 and 57% with monosymptomatic enuresis for the experimental and control groups, respectively. Many had tried treatments previously, including alarm training in 10% experimental and 12% controls, desmopressin in 22% of both and tricyclic antidepressants in 5% and 4% respectively ( Table   1) . As the treatment outcomes were similar between those with primary and secondary enuresis, we combined primary and secondary enuresis when reporting outcomes. (118/177) controls had a complete or partial response, and 26% versus 34%
respectively had a nonresponse ( Table 2 ). The median reduction in wet nights was 10 versus 9 nights per fortnight in the experimental and control groups respectively (p=0.029) ( Table 3) .
Length of treatment:
The median length of treatment was 54 days for the experimental group and 61 days for controls (p=0.72). The median time to achieve a full response (for those who became dry) was similar, with 46 versus 50 days respectively (p=0.98).
Arousal response:
The median percentage of wet nights the child woke to the alarm was 88% in the experimental group and 77% for controls (p=0.003) ( Table 3 and 4) .
Adherence to alarm training:
The percentage of nights during treatment that the child wore the alarm was similar between the two groups, with 91% experimental and 89% controls (p=0.32) ( Table 3) . Children who achieved a full response on average wore the alarm more consistently than those who did not achieve a full response (94% versus 86%, respectively, p<0.001). (<0%) 4 (2) 8 (5) *Categories or response according to ICCS definitions 11 Based on change in wetting at the end of treatment compared to baseline †Chi-square test comparing change in wetting from baseline between the two treatment groups. Adverse effects were similar between groups (14% versus 16% respectively) ( Table   3 ). The most commonly reported adverse effect was sleep disturbance (14 versus 17).
Other reported adverse effects included the child being frightened by the alarm (2 versus 4) and alarm training triggering sleepwalking and nightmares (1 in each group). Overall, most children (90% versus 86%) and families (95% versus 93%)
reported being happy with the treatment received.
Relapse: Relapse rates assessed at 6 months after cessation of alarm training were similar in the two arms, with 67% of those who had achieved a full response in the experimental group and 62% in the control group reporting relapse (p=0.50) ( Table   3 ).
Subgroup analysis of children with monosymptomatic enuresis:
There were 199 children with monosymptomatic enuresis, with 98 allocated to the code-word alarm and 101 to the control alarm ( Figure 1 ). Of those with monosymptomatic enuresis, 66% (65/98) in the experimental group versus 52%
(53/101) controls achieved full response by 16 weeks (p=0.047).
The median reduction in wet nights was greater in the code-word alarm group, with 12 nights reduction per fortnight versus 9 nights compared with baseline (p=0.01).
The median percentage of wet nights the child woke to the alarm was also higher for the experimental group, with 89% versus 79% of wet nights waking (p=0.006). The median length of treatment and the relapse rates at 6 months were similar in the two arms (Table 3) .
DISCUSSION
In our study the full response rate was not higher for the code-word alarm group than controls for the whole cohort, although there was a small but significant reduction in the median number of wet nights (10 versus 9 nights per fortnight) and increase in median percentage of wet nights the child woke to the alarm (88% versus 77%)
favouring the code-word alarm. We propose that the inclusion of participants who had non-monosymptomatic enuresis (who may or may not have received treatments for their lower urinary tract symptoms), those who had previous failed treatment, as well as those who chose to stop alarm training before achieving a full response contributed to the lack of difference seen between the two groups. Children with nonmonosymptomatic enuresis are more likely to have multiple episodes of wetting at night compared with the monosymptomatic group, which would make alarm training more difficult and may result in desensitisation to the alarm. We included these children in our study for ethical reasons because they represent a typical clinical population who commonly use alarm therapy.
This is the largest study of alarm therapy for treating enuresis, and one of the few head to head studies comparing a novel alarm with the best current treatment 7 .
Interestingly Van Londen's paper demonstrated that immediately rewarding the child for correct behaviour at the time of waking was more effective than delayed rewards for dry nights the following day, and that both were better than receiving no reward 13 .
In our study, we found that delayed reward for recall of the code word (which required increased arousal at the time of wetting) was better than delayed reward for dry nights, suggesting that rewarding correct behaviour is better than rewarding for a desired outcome. The cost of the two alarms used in our study is very similar.
Limitations of this study include that it was not powered to adequately address the large proportion of children with non-monosymptomatic enuresis 14 , which was double the expected in the population, possibly due to the setting of a tertiary paediatric centre with more complex referrals 14 . Another limitation was our choice of a full response as the primary outcome which may have been too stringent, as clinically significant differences in other outcomes may have been missed.
The overrepresentation of children with non-monosymptomatic enuresis in our study is likely to bias our study towards the null. Hence, we conducted a post-hoc subgroup analysis of the monosymptomatic group, as most published studies of alarm therapy including the Cochrane systematic review 7 predominantly included children with monosymptomatic enuresis. Our post-hoc analysis found a significant difference in full response rate, median reduction in wet nights and median percentage of wet nights the child woke to the alarm suggesting that the code-word alarm is more effective than the control alarm in monosymptomatic enuresis. These results are consistent with what was found in the Cochrane review 7 . However, as this analysis was conducted post-hoc, these results should be interpreted with caution.
CONCLUSIONS
The findings from our study have implications for clinicians who treat children with nocturnal enuresis. The focus of alarm training has traditionally been on achieving night dryness. Encouraging parents to reward arousal (rather than rewarding dry nights) when their child is alarm training is relatively simple and is likely to be associated with a reduction in wet nights, although this may not necessarily lead to complete resolution of wetting. PC conceptualised the project and is responsible for the design, conduct, analysis and write up, PS, MK and SH were involved in data collection, data analysis and write up,
AT and PM were involved in the data analysis and write up and JC was involved in the design, analysis and write up of the study. All authors had full access to all of the data in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.
